Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PTC Therapeutics Inc Closes Initial Public Offering


Tuesday, 25 Jun 2013 11:52am EDT 

PTC Therapeutics Inc announced the closing of its initial public offering of 9,627,800 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts, including 1,255,800 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount. J.P. Morgan and Credit Suisse acted as joint book-running managers for the offering. Cowen and Company acted as co-lead manager and Wedbush PacGrow Life Sciences as co-manager. 

Company Quote

36.97
-0.93 -2.45%
22 Oct 2014